Literature DB >> 19707296

Specific gene hypomethylation and cancer: new insights into coding region feature trends.

Elias Daura-Oller1, Maria Cabre, Miguel A Montero, Jose L Paternain, Antoni Romeu.   

Abstract

Giving coding region structural features a role in the hypomethylation of specific genes, the occurrence of G+C content, CpG islands, repeat and retrotransposable elements in demethylated genes related to cancer has been evaluated. A comparative analysis among different cancer types has also been performed. In this work, the inter-cancer coding region features comparative analysis carried out, show insights into what structural trends/patterns are present in the studied cancers.

Entities:  

Keywords:  CpG islands; cancer; epigenetics; hypomethylation

Year:  2009        PMID: 19707296      PMCID: PMC2720671          DOI: 10.6026/97320630003340

Source DB:  PubMed          Journal:  Bioinformation        ISSN: 0973-2063


Background

Alterations of DNA methylation have been recognized as an important component of cancer development [1]. Hypomethylation generally arises earlier and is linked to chromosomal instability and loss of imprinting [2-6], whereas hypermethylation is associated with promoters and can arise secondary to gene silencing [7-9], but might be a target for epigenetic therapy [10]. It is not currently known why certain CpG islands are hypermethylated or hyphometylated in specific cancers but not in others [1]. Some of these events have been observed in vitro and using in vivo animal models [2-4,11,12] but their relative importance in human disease is not understood. Recent studies suggest that some methylation patterns are discernible in risk groups and certain diseases. Indications are that the hypomethylation of specific DNA repeat elements or genes can be disease-specific [13]. These repeat sequences may be transposable elements found interspersed throughout the genome, or large repeat sequences and simple repeat ones, such as DNA satellites, that are found commonly in heterochromatin. Hypomethylation of satellites and retroelements together should account for the greater part of the decrease in methyl-cytosine content in cancer cells. Decreased methylation of single-copy genes does not contribute significantly to the decrease in quantity, but whether hypomethylation may lead to the reactivation of genes silenced in normal cells is an important issue. The site reported to be hypomethylated in several human cancers is located within the coding region. It may become demethylated in cancers as a consequence of global hypomethylation or may reflect increased transcriptional activity [14,15,16]. The relationship between hypomethylation of specific genes and repeat elements within the genome may serve as useful diagnostic indicators for disease [13]. Nowadays, more information is required with regard to what repeat elements are specific to what diseases and whether this information can be used to predict disease onset or progression. Thus, the occurrence of G+C content, CpG islands, repeat and retrotransposable elements in demethylated genes related to cancer has been evaluated in this work. Moreover, a comparative analysis among different cancer types has also been performed in order to elucidate what structural trends/patterns are present in the studied cancers.

Methodology

All selected genes were compiled from the recent literature (see Table 1 in supplementary material) and were collected from the NCBI nucleotide database [21]. The sequence characteristics of the coding regions of each gene were examined in the analysis. For CpG dinucleotide analysis, we used the NEWCPGREPORT program [17], and the total number of CpG islands was counted. For the repeat element analysis, the Repeat Masker program [18] was used and for tandem repeat analysis, the ETANDEM program [19] was used. All classes of repeat elements output from Repeat-Masker were collected. We used ETANDEM to obtain numbers of tandem repeat elements ranging from 5 bp to 100 bp. All the statistical calculations were performed using the Minitab software [20].

Discussion

Firstly, a list of genes that are demethylated in cancer according to the recent existing literature was compiled (Table 1 in supplementary material). We observed that these genes are related with 7 different cancer types: breast, colon, lung, ovarian, pancreatic, prostate and testicular. As it can be seen in Table 1, the ranges of genes affected by hypomethylation includes growth regulatory genes, enzymes, developmentally critical genes and tissue specific genes such as germ cell-specific tumour antigen genes, etc. Then, we selected 6 representative structural descriptors (variables) for the structural study: GC content, CpG islands, Simple Repeats (SR), Low Complexity (LC), Large Tandem Repeats (LTR) and SINE Alu. The [bp]% sequence characteristics of these descriptors were calculated for all gene coding regions. As it has stated before, the site reported to be hypomethylated in several human cancers is located within the coding region [13,15]. For this reason, the structural information related with this region could be very useful in order to develop a first stage approximation. Once the values for all the structural descriptors were calculated, we performed a distribution analysis of the [bp]% differences across all 7 cancer types. In order to evaluate tendencies, we also calculated the median and the average numbers for each descriptor and cancer types (see Figure 1).
Figure 1

Boxplot graphs (median and interquartile) with the comparison of the different [bp] % seuence characteristic distributions across the different cancer types*. Note that the different average numbers are connected by a drawing line.

From the boxplot data comparisons in Figure 1, we observed how all the GC content, CpG islands, Simple Repeats (SR), Low Complexity Elements (LC) and Large Tandem Repeats (LTR) [bp] % average distributions follow the same trend in all the different cancers studied. In contrast, the SINE Alu [bp] % average distribution follows the opposite one. Apart form that, analyzing the value’s magnitude it can be observed that in general, the genes involved in the ovarian cancer show the smallest values for [bp] % and the largest value for the SINE Alu descriptor. On the other hand the major part of colon, pancreatic and prostate [bp] % values are the largest ones in all cases except for the SINE Alu descriptor (see Figure 1). The relationship between CpG islands density and the GC content is logical taking into account that CpG islands are genomic regions that contain a high frequency of CG dinucleotides. Besides, the SR, LC and LTR elements follow the same CpG island trend while the SINE Alu follows the opposite one. To date, there seems to be very few comparative analyses of CpG islands density and their correlations with other genome features. Here, it seems clear that there is some structural mark/pattern that establishes a relationship among the different coding region features of the studied genes and so, a mark that relates different cancer types among them. After this preliminary approximation, we think that these observations would be related with different hypomethylation patterns observed in some specific cancers but not in others [1]. At this point, further investigation is required. Thus, we are studying the evolution of these trends in the sequences flanking the coding regions including the promoter sites. Our next objective will be the full identification of key structural characteristics that are unique to each cancer type. Moreover, a future detailed and extensive theoretical analysis of the methylation profiles of these sequences and their characteristics may reveal higher specificity and epigenetic signatures for cancer detection.
  16 in total

1.  Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9.

Authors:  Vesco Mutskov; Gary Felsenfeld
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

2.  Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells.

Authors:  Adam R Karpf; Sei-ichi Matsui
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

Review 3.  DNA hypomethylation and human diseases.

Authors:  Ann S Wilson; Barbara E Power; Peter L Molloy
Journal:  Biochim Biophys Acta       Date:  2006-09-01

Review 4.  Causes and consequences of DNA hypomethylation in human cancer.

Authors:  Michèle J Hoffmann; Wolfgang A Schulz
Journal:  Biochem Cell Biol       Date:  2005-06       Impact factor: 3.626

5.  Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice.

Authors:  Takashi Sakatani; Atsushi Kaneda; Christine A Iacobuzio-Donahue; Mark G Carter; Sten de Boom Witzel; Hideyuki Okano; Minoru S H Ko; Rolf Ohlsson; Dan L Longo; Andrew P Feinberg
Journal:  Science       Date:  2005-02-24       Impact factor: 47.728

6.  Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells.

Authors:  Myungjin Kim; Binh N Trinh; Tiffany I Long; Shirley Oghamian; Peter W Laird
Journal:  Nucleic Acids Res       Date:  2004-10-27       Impact factor: 16.971

Review 7.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

Review 8.  DNA methylation in urological malignancies (review).

Authors:  W A Schulz
Journal:  Int J Oncol       Date:  1998-07       Impact factor: 5.650

9.  Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.

Authors:  Clare Stirzaker; Jenny Z Song; Ben Davidson; Susan J Clark
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

Review 10.  Epigenetics in human disease and prospects for epigenetic therapy.

Authors:  Gerda Egger; Gangning Liang; Ana Aparicio; Peter A Jones
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

View more
  17 in total

Review 1.  Aberrant DNA methylation in human cancers.

Authors:  Wen Li; Bi-Feng Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

2.  Optical Trapping Nanometry of Hypermethylated CPG-Island DNA.

Authors:  Csaba I Pongor; Pasquale Bianco; György Ferenczy; Richárd Kellermayer; Miklós Kellermayer
Journal:  Biophys J       Date:  2017-01-18       Impact factor: 4.033

Review 3.  Rap2B GTPase: structure, functions, and regulation.

Authors:  Zhesi Zhu; Jiehui Di; Zheng Lu; Keyu Gao; Junnian Zheng
Journal:  Tumour Biol       Date:  2016-03-24

Review 4.  Diagnosis of Lung Cancer by SHOX2 Gene Methylation Assay.

Authors:  Lele Song; Haotian Yu; Yuemin Li
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

5.  A systematic pan-cancer analysis identifies RIOK3 as an immunological and prognostic biomarker.

Authors:  Jian Li; Ruili Sun; Lixiang He; Guoyi Sui; Wenyu Di; Jian Yu; Wei Su; Zenggang Pan; Yu Zhang; Jinghang Zhang; Feng Ren
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

6.  S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer.

Authors:  Jin Luo; Yan-Ni Li; Fei Wang; Wei-Ming Zhang; Xin Geng
Journal:  Int J Biol Sci       Date:  2010-12-06       Impact factor: 6.580

Review 7.  Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability.

Authors:  Hu Wang; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Jong-Hun Lee; Ah-Ng Tony Kong
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

8.  Using epigenomics data to predict gene expression in lung cancer.

Authors:  Jeffery Li; Travers Ching; Sijia Huang; Lana X Garmire
Journal:  BMC Bioinformatics       Date:  2015-03-18       Impact factor: 3.169

9.  DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth.

Authors:  M X Da; Y B Zhang; J B Yao; Y X Duan
Journal:  Braz J Med Biol Res       Date:  2014-09-30       Impact factor: 2.590

10.  Peripheral blood methylation profiling of female Crohn's disease patients.

Authors:  Andrew Y F Li Yim; Nicolette W Duijvis; Jing Zhao; Wouter J de Jonge; Geert R A M D'Haens; Marcel M A M Mannens; Adri N P M Mul; Anje A Te Velde; Peter Henneman
Journal:  Clin Epigenetics       Date:  2016-06-08       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.